This was in line with a positive correlation between sPD-L1 levels in the CSF of MS patients and increased AhR activity (Fig. 2p and Table 1), indicating that microbial metabolites may contribute to immune checkpoint signaling in the CNS of MS patients. Here, AHR is linked to myeloid sarcoma.